Literature DB >> 1831126

Influence of ganglioside GM3 and its breakdown products on lymphoblastic transformation and T-suppressor activity.

E V Dyatlovitskaya1, A B Koroleva, V S Suskova, B V Rozynov, L D Bergelson.   

Abstract

The influence of ganglioside GM3 and some of its breakdown products on phytohemagglutinin-induced blast transformation of human lymphocytes and concanavalin-A-induced T-suppressor activity was studied. The structures of two major hydrolysis products of GM3 were established by negative-ion fast-atom-bombardment mass spectrometry as neuraminyllactosylsphingosine (NeuLacSph) and neuraminyllactosylceramide (NeuLacCer). Both substances were shown to be potent inhibitors of mitogen-induced lymphoblastic transformation whereas their acetylation products NeuAcLacSphAc and GM3 did not affect the proliferative response of lymphocytes to phytohemagglutinin. On the other hand, only GM3 and NeuLacSph were able to enhance concanavalin-A-induced T-suppressor activity. On the basis of these data, it is suggested that the effects of GM3 and its breakdown products on lymphoblastic transformation and T-suppressor activity must rest on different mechanisms and that N-deacylation of GM3 appears to be an essential step in conversion of the ganglioside into an inhibitor of lymphocyte blast transformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831126     DOI: 10.1111/j.1432-1033.1991.tb16165.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides.

Authors:  C Dumontet; A Rebbaa; J Bienvenu; J Portoukalian
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

Review 2.  Gangliosides and antitumor immunity.

Authors:  L D Bergelson
Journal:  Clin Investig       Date:  1993-08

3.  Significant inhibition of hybridoma cells by exogenous application of ganglioside GM3, a possible modulator of cell growth in vitro.

Authors:  H Brandt; J Müthing; J Peter-Katalinić; J Lehmann
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.